UWMC vs CLOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 05, 2026
UWMC
CLOV
Investment Advisor Scores
CLOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | UWMC | CLOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.0671 | 37.7358 | UWMC |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -70.6% | 55.6% | CLOV |
| Earnings Growth | 277.8% | 0.0% | UWMC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.2/100 | 53.2/100 | CLOV |
| Profit Margin | -1.3% | -0.7% | CLOV |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
UWMC
DistributionPrice near a flattening SMA50 (slope -1.6%) with fading momentum, RSI 43
CLOV
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 57
Fundamentals Snapshot
| Metric | UWMC | CLOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 5.4 | 27.1 |
| Trailing P/E | — | 497.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.6% | 0.5% |
| Gross Margin | 1.0% | 0.2% |
| Operating Margin | 0.3% | 0.0% |
| EPS | 0.00 | 0.01 |
| Dividend Yield | 0.22% | — |